Quantum Biopharma Ltd. Files April 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Apr 10, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Apr 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
Quantum Biopharma (fka FSD Pharma) filed their April 6-K, confirming 20-F reporting.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on April 10, 2025, for the month of April 2025. The company, incorporated in A6 with its principal executive offices in Toronto, Canada, is a pharmaceutical preparations company. This filing indicates they are submitting their report under Form 20-F.
Why It Matters
This filing provides an update on Quantum Biopharma's regulatory reporting status, confirming their submission of a Form 6-K and adherence to reporting requirements for foreign private issuers.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new financial or operational information that would indicate a change in risk.
Key Numbers
- 001-39152 — Commission File Number (Identifies the company's filing with the SEC)
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Filer of the 6-K report
- FSD Pharma Inc. (company) — Former name of the registrant
- 20250410 (date) — Filing date and period of report
- 001-39152 (other) — Commission File Number
- Form 20-F (document) — Annual report form filed by the registrant
- Form 6-K (document) — Report of Foreign Private Issuer
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of April 2025.
What was Quantum Biopharma Ltd. formerly known as?
Quantum Biopharma Ltd. was formerly known as FSD Pharma Inc., with a date of name change on March 27, 2019.
Which annual report form does the registrant indicate it files?
The registrant indicates by check mark that it files annual reports under cover of Form 20-F.
Where are Quantum Biopharma Ltd.'s principal executive offices located?
The principal executive offices are located at 55 University Ave., Suite 1003, Toronto, Ontario M5J2H7, Canada.
What is the Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd.?
The Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 10, 2025 regarding Quantum Biopharma Ltd. (QNTM).